Sell
Thesis MAINTAINING
×
Valuation EXPENSIVE
·
Method PB
HIGH 12.1pts from 45 ↓2.0 over 7d stable 7d

Investment Thesis

Strong — all assumptions holding Maintaining — minor concerns, thesis intact Weak — key assumptions under pressure Broken — critical assumption invalidated
Status MAINTAINING
Conviction 57 / 100
Time Horizon 12-18 months
INCOME VALUE Over the next 12-18 months, Carlyle Group Inc. will deliver consistent shareholder returns through diversified fee-related earnings growth and robust capital distributions, supported by strong fundraising and disciplined margin expansion.

Conviction vs. Price

Assumptions

Holding — assumption intact At Risk — evidence weakening Broken — assumption invalidated Critical — if broken, thesis fails
BEAT — exceeded target MEET — met expectations MISS — missed target Insufficient Data
#1 GROWTH AT_RISK 59

Carlyle will achieve sustained Assets Under Management (AUM) growth, driven by strong fundraising across Global Credit, AlpInvest, and Global Wealth segments, and a constructive exit environment.

GROWTH 40% VOLUME 60%
Quarterly Checkpoint: Q1CY26 Revenue >= $863.8M (representing >= 29.6% YoY growth) with Net Profit >= $358.1M (Q4CY25: $996M Revenue, $358.1M Net Profit; Anchor floor applied)
Thesis Horizon Target: CY26 total inflows >= $55B and AUM >= $500B (CY25: $54B inflows, $477B AUM; mgmt guided 'diversified fundraising pipeline')
#2 CRITICAL FINANCIAL HEALTH AT_RISK 52

Fee-Related Earnings (FRE) will continue to expand, driven by increasing scale across the platform and sustained operating discipline, leading to further margin improvement.

COGS 50% PRICING 50%
Quarterly Checkpoint: Q1CY26 OPM% >= 47.5% (Q4CY25: 47.0% FRE Margin; mgmt guided 'margins will further expand' and 'continued operating discipline')
Thesis Horizon Target: CY26 full-year FRE >= $1.40B with FRE margin >= 48% (Raised from $1.35B following record FY25 performance exceeding initial guidance)
#3 CRITICAL FINANCIAL HEALTH AT_RISK 47

Distributable Earnings (DE) will remain robust, enabling continued significant capital returns to shareholders via dividends and share repurchases, while maintaining a stable balance sheet.

DEBT 50% PRICING 50%
Quarterly Checkpoint: Q1CY26 Net Profit >= $358.1M (Q4CY25: $358.1M; Anchor floor applied; mgmt guided 'solid momentum' and 'improving exit conditions')
Thesis Horizon Target: CY26 full-year DE >= $1.8B and shareholder capital returns >= $1.25B (CY25: $1.7B DE, $1.2B capital returns, mgmt: 'disciplined capital allocation')
#4 GOING CONCERN HOLDING 80

No material governance issues, regulatory enforcement actions, or unforeseen leadership transitions will emerge to disrupt business operations or shareholder confidence.

GOING_CONCERN 100%
Quarterly Checkpoint: No regulatory fines > $500M, no SEC investigations, and no unplanned leadership transitions in Q1CY26
Thesis Horizon Target: No major governance or regulatory events (e.g., forced divestitures, significant restatements) through CY26 (KB: Evolving SEC rules a general risk)
Transcript Checkpoint: Successful leadership transition for CFO Justin Plouffe with no material operational disruptions

Recent Developments

Structural Tactical
GROWTH STRUCTURAL Mar 31, 2026

Bharti Airtel’s Nxtra gets $1 billion from Carlyle, Alpha Wave - The Economic Times

Selected by U.S. Army to build two $2 billion AI-focused data centers and committed $240 million to India's Nxtra Data Limited.

GROWTH TACTICAL Mar 07, 2026

A Look At Carlyle Group (CG) Valuation As New Capital Raise And Buyback Plan Takes Shape - simplywall.st

Authorized a new $2 billion share repurchase program and set a strategic target to raise $200 billion in new capital by 2028.

GROWTH TACTICAL Mar 06, 2026

Taylor Swift’s Carlyle Plea Showcases Private Equity’s Reach - pe-insights.com

Achieved record $54B capital inflows and 47% FRE margin in FY2025, setting a new $200B fundraising target by 2028.

GROWTH TACTICAL Mar 05, 2026

A 10% owner sold 19.8 million shares valued at $624.17 million, representing approximately 3.33% of total market capitalization.

GROWTH TACTICAL Mar 04, 2026

Medline’s PE Backers Start Stake Sale Worth $3.4 Billion - Bloomberg

Initiated $3.4 billion stake sale in portfolio company Medline and reached agreement to acquire SUGIKO, accelerating capital rotation.

GROWTH TACTICAL Feb 27, 2026

Carlyle Group aims to raise more than $200 billion by 2028 - marketscreener.com

Carlyle Group announced a strategic target to raise over $200 billion in new capital by 2028 to drive AUM and fee growth.

GROWTH TACTICAL Feb 26, 2026

Carlyle Secured Lending (CGBD) Earnings Call - The Globe and Mail

Closed latest secondary fund at $20 billion and launched a Structured Credit Partners JV with Sixth Street targeting $7 billion in AUM.

GROWTH STRUCTURAL Feb 24, 2026

Carlyle : provides a structured capital solution to Peloton Computer Enterprises to support growth - marketscreener.com

Closed latest secondary fund at $20 billion and saw portfolio company Quest Global valued at $4.5 billion in a minority stake sale.

GROWTH STRUCTURAL Feb 19, 2026

Banks Pounce on M&A Comeback With $100 Billion of Buyout Debt - Bloomberg.com

Carlyle completed the sale of portfolio company Arctic Glacier, LLC to Reddy Ice, LLC, marking a successful private equity exit.

Investor Documents